| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-12-2301 |
| P698 | PubMed publication ID | 23288917 |
| P50 | author | Josep Tabernero Caturla | Q37387600 |
| Jose R. Arribas | Q37838345 | ||
| Roger Gomis | Q42846404 | ||
| Mariano F Zacarias Fluck | Q58888732 | ||
| Joaquin Arribas | Q80171901 | ||
| P2093 | author name string | José Baselga | |
| Jordi Giralt | |||
| Rocio Vicario | |||
| Josep Villanueva | |||
| Francesc Canals | |||
| Marc Guiu | |||
| Kim Pedersen | |||
| Josep Lluís Parra-Palau | |||
| Cristina Bernadó Morales | |||
| Antonio Luque-García | |||
| Pier Davide Angelini | |||
| Nerea Peiró Navalpotro | |||
| P2860 | cites work | Genes that mediate breast cancer metastasis to lung | Q29547479 |
| A multigenic program mediating breast cancer metastasis to bone | Q29614308 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cancer metastasis | Q120912394 |
| P304 | page(s) | 450-458 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Constitutive HER2 signaling promotes breast cancer metastasis through cellular senescence | |
| P478 | volume | 73 |
| Q36902984 | Activating mutations and senescence secretome: new insights into HER2 activation, drug sensitivity and metastatic progression |
| Q52579718 | Anti-cancer therapy: senescence is the new black. |
| Q90417537 | Cellular Senescence as a Therapeutic Target for Age-Related Diseases: A Review |
| Q38270752 | Challenges and opportunities for cell line secretomes in cancer proteomics |
| Q41962867 | Clearance of senescent hepatocytes in a neoplastic-prone microenvironment delays the emergence of hepatocellular carcinoma. |
| Q37688860 | Detection of cellular senescence within human invasive breast carcinomas distinguishes different breast tumor subtypes |
| Q57063810 | ERBB2 signaling drives supporting cell proliferation in vitro and apparent supernumerary hair cell formation in vivo in the neonatal mouse cochlea |
| Q38875168 | Effect of cellular senescence on the growth of HER2-positive breast cancers. |
| Q39434311 | Epithelial cell senescence: an adaptive response to pre-carcinogenic stresses? |
| Q54272130 | Everything old is neu again: cellular senescence in HER2-positive breast cancer. |
| Q64069811 | HER2 and p95HER2 differentially regulate miRNA expression in MCF-7 breast cancer cells and downregulate MYB proteins through miR-221/222 and miR-503 |
| Q41551956 | HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response |
| Q99558040 | Human innate immune cell crosstalk induces melanoma cell senescence |
| Q36962531 | Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells |
| Q52876533 | Myofibroblasts have an impact on expression, dimerization and signaling of different ErbB receptors in OSCC cells. |
| Q36524759 | Overexpression of ErbB2 renders breast cancer cells susceptible to 3-BrPA through the increased dissociation of hexokinase II from mitochondrial outer membrane |
| Q47648304 | Persistent activation of interlinked type 2 airway epithelial gene networks in sputum-derived cells from aeroallergen-sensitized symptomatic asthmatics. |
| Q40248157 | Potentially functional variants in lncRNAs are associated with breast cancer risk in a Chinese population. |
| Q36107363 | Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases. |
| Q37694756 | Radiosensitizing effect of lapatinib in human epidermal growth factor receptor 2-positive breast cancer cells |
| Q28081010 | Retinoids induce cellular senescence in breast cancer cells by RAR-β dependent and independent pathways: Potential clinical implications (Review) |
| Q35939308 | Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence. |
| Q39456823 | SASP: Tumor Suppressor or Promoter? Yes! |
| Q39449103 | Senescent cells: an emerging target for diseases of ageing |
| Q36064912 | The Therapeutic Challenge of Targeting HER2 in Endometrial Cancer |
| Q39027058 | The failure in the stabilization of glioblastoma-derived cell lines: spontaneous in vitro senescence as the main culprit |
| Q47155260 | Towards individualized cancer therapy: Challenges and prospects. |
| Q47814746 | Tumor Promoting Aspects of Senescence in Cancer Progression |
| Q93000927 | Unmasking senescence: context-dependent effects of SASP in cancer |
| Q38673589 | When Good Turns Bad: Regulation of Invasion and Metastasis by ErbB2 Receptor Tyrosine Kinase |
| Q57042030 | p95HER2-T cell bispecific antibody for breast cancer treatment |
Search more.